End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
155,930 CLP | 0.00% | 0.00% | +14.33% |
12:39pm | US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug | RE |
06-24 | US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit | RE |
Official Publications
SEC Filing 10Q-2 | CO | |
SEC Filing 8K | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Minutes of the general assembly | CO | |
SEC Filing 8K | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
Dividends | CO | |
Acquisition | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
Slide show Q3 | CO | |
SEC Filing 8K | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO |
- Stock Market
- Equities
- JNJ Stock
- JNJCL Stock
- News Johnson & Johnson
- Official Publications